"Top 20 Translational Researchers of 2015"

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing

Researchers Identify Flu-Fighting Pathways and Genes Essential for Influenza A Immune Defense

Mount Sinai to Lead Discussions on Transgender Health, Psychedelic Therapeutics and Long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival

Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection

Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course

Leader in Global Health and Emerging Pathogens at Mount Sinai Elected to the National Academy of Sciences

Prior Dengue Virus Infection May Cause Severe Outcomes Following Zika Virus Infection During Pregnancy, Mount Sinai Study Shows

"New Ideas to Fight the Flu" - Lucette Lagnado

"The Universal Flu Shot Moves Within Reach"

"100 Year Shadow"

"Migrating birds create flu bonanza for scientists to study" - Kathy Young